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South Africa’s tuberculosis treatment
success lags 14% behind 2 other HIV-
ravaged countries, Kenya and Tanzania,
leading to the ‘inescapable conclusion’
that we need to examine the
performance of our own systems
instead of blaming HIV.
This is the opinion of Dr Lindiwe
Mvusi, Director of South Africa’s
national TB control programme.
Mvusi told Izindaba that although the
national health department’s TB
detection rates compared favourably
with those in Kenya and Tanzania, local
treatment efficacy needed boosting in
nearly every province.
In spite of far fewer resources and
less sophistication, Kenya and Tanzania
were outperforming us ‘by doing the
basics correctly’, and having small
laboratory rooms for TB smear
microscopy at virtually every clinic.
‘That enables them to diagnose then
and there and start DOTS immediately
by connecting the patient with a person
in their community,’ Mvusi explained.
Not even close
South Africa does not have smear
microscopy in clinics and relies on the
National Health Laboratory Service for
providing this service from district
hospitals upwards. 
Mvusi put recent improved detection
down to improved TB awareness
among both health care staff and the
general population.
One-quarter of a million South
Africans were diagnosed with TB in
2003 (latest available statistics and
double where it was 5 years ago), with
an average increase of some 31 000 cases
every year.
According to the latest Stats-SA
Mortality and Causes of Death figures,
TB moved from being the leading cause
of death in 4 provinces in 1997 through
being the leading cause of death in all 9
provinces in 1999 to being the leading
cause of death in 7 provinces in 2001
(second leading cause of death in
Limpopo and the Free State).
Mvusi said that with 68% of the
country’s new smear-positive TB
patients successfully completing
treatment, 7% of the remainder dying
and 12% defaulting, South Africa was
‘not even close’ to its targeted cure rate
of 85%. A further 14% of patients
transferred to other health facilities and
their treatment outcome was unknown.
These included many public hospital
and private sector patients and those
treated by some mines, the military and
Correctional Services. 
‘Once we get a handle on these, the
statistics will surely take a further
upward jump — without a change in
actual incidence,’ Mvusi said.
Swallowing a bitter pill
Kenya and Tanzania’s TB treatment
success rates stood at 80% and 81%
while their HIV-positive prevalence
rates stand at 6.7% and 8.8%,
respectively. South Africa’s HIV-positive
prevalence was 29.7% last year.
The South African health department
puts the rate of HIV co-infection at 55%
of all TB patients and with steep
increases in HIV prevalence in the mid-
90s, greatly increasing numbers of
people are presenting with severely
compromised immunity.
Mvusi believes that patient
compliance, while lying at the heart of
successful treatment, is ‘an over-
simplification’, because several systemic
preconditions implied by DOTS need to
be met first to allow patients to play
their part effectively.
Compliance secondary to...
These preconditions included
government committing sufficient
human and financial resources,
improved access to quality-assured TB
sputum microscopy, special attention
for case detection among HIV-infected
people and other high-risk groups,
standardised short-course
chemotherapy with socially supportive
treatment services including DOTS, and
uninterrupted quality-assured anti-TB
drugs with reliable drug procurement
and distribution systems, plus recording
and reporting systems that allowed for
individual patient and overall
programme assessment.
Mvusi warned that while ‘99.5%’ of
sub-districts had adopted and
implemented the community-based
treatment approach, general weaknesses
in the primary health care system had
led to the DOTS programme regressing
in many.
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Labs and staff the keys
Inadequate decentralisation of
laboratory services meant turnaround
time on smear microscopy tests varied
from 2 days to 2 weeks (the Eastern
Cape and Limpopo tending towards 2
weeks). This sent ‘the wrong signal’ to
patients, while a shortage of health care
professionals and high turnover of
voluntary treatment supporters had
undermined the quality of crucial face-
to-face communication.
Few patients receive a thorough
explanation of their treatment or the
implications of interrupting it, simply
because nurses faced too much pressure
and could not afford the time this took.
Volunteers on the other hand tended
to ‘drop out’ because their activity was
unremunerated, often under-recognised
and under-supervised. ‘They just feel
oppressed by the insoluble problems of
poverty that their patients carry,’ Mvusi
observed.
Only the Free State had a database of
all community health workers and
managers, enabling their activities,
geographical location and stipend
payments to be mapped, thus
preventing duplication with NGOs and
better resource distribution. This had
made the Free State the second most
successful province for TB treatment
after the Western Cape.
NGO/government ‘apartheid’
Weak links between NGOs and
government clinics were a source of
serious concern.
‘In most areas NGOs do their own
thing and health authorities are not
even aware they’re there – much closer
collaboration is required between
district managements and facility
managers just to set out terms of
reference, reporting mechanisms and
indicators.’
While TB was part of the
government’s mass media campaign on
HIV and AIDS (Khomanani), it received
relatively low priority at just 4% of the
R106-million Khomanani budget between
2001 and 2004.
Mvusi said the only other major media
project to deal with TB was Soul City.
Unsurprisingly, while there was a
high public awareness of TB (> 90%),
knowledge of symptoms remained quite
low. Only 65% of respondents in 2
Khomanani surveys identified a
persistent cough as symptomatic.
Mvusi believes this shows that the
public’s grasp of treatment is ‘even
more limited’.
‘In short, the public health sector has
developed a basic technical ability to
manage TB at primary health care level
countrywide, but has not created a
patient-friendly and supportive service
– despite TB being a condition that cries
out for these qualities.’
A study done by the MRC and US
Centers for Disease Control and
prevention had identified the main risk
factors for treatment default as:
•  the quality of the relationship
between patient and service provider
•  substance use during treatment
•  socio-economic factors
•  perceptions about the effects and
side-effects of treatment.
Mvusi said these highlighted a need
to strengthen health system support
for patients and their families. ‘We
need to sensitise health workers to the
weight of social factors in determining
treatment outcomes and improve
communication with patients.
Treatment support must be conducted
in a way that patients feel empowered
rather than policed,’ she said.
Hope for staffing crisis?
Mvusi is pinning much of her hope for
creating laboratories at the most far-
flung clinics on the new mid-level
health worker category currently being
legislated for.
The mid-level worker laws will
probably only be finalised in the 2006/7
financial year, meaning candidates
would still need to be trained.
The delay will have far-reaching
effects in a TB fight in which more than
55% of the 125 000 known TB cases
were  attributed to HIV infection last
year (SA National Tuberculosis
Association (SANTA) figures). Mvusi
said the comparable figure in KwaZulu-
Natal stood at 60%.
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The South African health
department puts the rate of
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The TB ward at Tugela Ferry Hospital.
